IRIS
CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.942
AS - Asia 2.404
NA - Nord America 1.865
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 32
OC - Oceania 3
Totale 9.729
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.008
US - Stati Uniti d'America 1.801
SG - Singapore 741
CN - Cina 521
VN - Vietnam 415
HK - Hong Kong 345
IT - Italia 323
BR - Brasile 284
IE - Irlanda 245
KR - Corea 116
DE - Germania 104
IN - India 98
GB - Regno Unito 75
JP - Giappone 39
FR - Francia 34
AR - Argentina 26
MX - Messico 25
NL - Olanda 23
CA - Canada 21
BD - Bangladesh 20
ID - Indonesia 17
PL - Polonia 16
SE - Svezia 15
FI - Finlandia 13
TR - Turchia 13
AT - Austria 12
CO - Colombia 12
ES - Italia 12
ZA - Sudafrica 11
EC - Ecuador 10
LT - Lituania 10
UA - Ucraina 9
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
PK - Pakistan 7
BE - Belgio 6
CZ - Repubblica Ceca 6
EG - Egitto 6
GR - Grecia 6
IL - Israele 6
IR - Iran 6
MA - Marocco 6
PE - Perù 6
SA - Arabia Saudita 6
CH - Svizzera 4
CR - Costa Rica 4
KG - Kirghizistan 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
RO - Romania 3
TW - Taiwan 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
Totale 9.601
Salva come PNG Salva come JPEG
Città #
Moscow 1.441
San Jose 384
Singapore 371
Hong Kong 334
Dublin 231
Santa Clara 201
Ashburn 139
Hefei 139
Chandler 132
Ho Chi Minh City 122
Seoul 115
The Dalles 113
Hanoi 100
Naples 85
New York 76
Bengaluru 65
Beijing 46
Munich 43
Los Angeles 42
Dallas 41
Da Nang 37
São Paulo 30
Princeton 22
Roxbury 22
Cambridge 20
Haiphong 20
Orem 20
Memphis 17
Chicago 16
Falkenstein 15
Bremen 13
Amsterdam 12
Atlanta 12
Hải Dương 12
Mexico City 12
Salerno 12
Tokyo 12
Caserta 11
Milan 11
Belo Horizonte 10
Chennai 10
Frankfurt am Main 10
Hillsboro 10
Stockholm 10
Avellino 9
Brooklyn 9
Biên Hòa 8
Boston 8
Denver 8
Des Moines 8
Houston 8
Istanbul 8
Manchester 8
Nuremberg 8
Warsaw 8
Bắc Ninh 7
Ercolano 7
Helsinki 7
Johannesburg 7
Liveri 7
Bexley 6
Brussels 6
Council Bluffs 6
Florence 6
Guarulhos 6
Lahore 6
Montreal 6
Napoli 6
Phoenix 6
Rome 6
San Francisco 6
Toronto 6
Boardman 5
Changsha 5
Curitiba 5
Damietta 5
Jacksonville 5
London 5
Mumbai 5
Nanjing 5
Nha Trang 5
Rio de Janeiro 5
Thanh Mỹ Tây 5
Vienna 5
Wroclaw 5
Baghdad 4
Barranquilla 4
Brno 4
Can Tho 4
Cape Town 4
Columbus 4
Duncan 4
Giugliano in Campania 4
Ha Long 4
Lappeenranta 4
Lima 4
Lisbon 4
Medford 4
Nonantola 4
Paris 4
Totale 4.918
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 197
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 184
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 164
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 159
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 157
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 142
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 137
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 137
HCC and molecular targeting therapies: Back to the future 135
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 133
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 133
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 130
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 127
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 127
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 127
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 122
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 120
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 119
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 117
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 116
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 114
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 114
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 112
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 112
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 111
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 110
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 109
Polypharmacy and major adverse events in atrial fibrillation 108
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 108
Insulin resistance and cancer: molecular links and clinical perspectives 104
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 104
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 104
Brugada syndrome and COVID-19 vaccines 104
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk 101
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 100
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 100
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 99
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 99
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 98
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 97
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 97
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 96
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 95
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 94
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 93
null 93
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 92
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 92
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management 90
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 89
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 89
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 88
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 88
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 88
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 87
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 87
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 85
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 82
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 79
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 78
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 78
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 72
Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad 71
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 71
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 62
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 62
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 59
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 53
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 52
IMPACT OF EMPAGLIFLOZIN AND METFORMIN COMBINATION THERAPY VS. METFORMIN MONOTHERAPY ON MASLD PROGRESSION IN TYPE 2 DIABETES: FINDINGS FROM THE IMAGIN STUDY 8
IMPACT OF EMPAGLIFLOZIN AND METFORMIN COMBINATION THERAPY VS. METFORMIN MONOTHERAPY ON MASLD PROGRESSION IN TYPE 2 DIABETES: FINDINGS FROM THE IMAGIN STUDY 4
Totale 9.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022186 0 1 8 19 33 8 4 4 11 16 29 53
2022/2023498 28 28 15 19 67 30 5 31 230 11 10 24
2023/2024363 34 17 13 25 77 63 9 9 8 28 30 50
2024/20251.341 13 17 5 26 204 140 209 124 194 115 119 175
2025/20267.218 369 429 375 300 634 3.680 476 306 266 150 137 96
2026/202767 43 24 0 0 0 0 0 0 0 0 0 0
Totale 9.729